Detalhe da pesquisa
1.
Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotide.
Nature
; 619(7971): 811-818, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407817
2.
Identification of novel neutralizing determinants for protection against HCV.
Hepatology
; 77(3): 982-996, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056620
3.
Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice.
Gut
; 72(3): 560-572, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918103
4.
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice.
J Hepatol
; 76(5): 1051-1061, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990750
5.
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro.
Antimicrob Agents Chemother
; 65(9): e0268020, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097489
6.
Toward a vaccine against hepatitis C virus.
Science
; 380(6640): 37-38, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023205
7.
Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles.
Microbiol Spectr
; : e0254622, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719195
8.
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir.
Viruses
; 15(9)2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766376
9.
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals.
iScience
; 26(2): 105949, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644321
10.
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.
Vaccines (Basel)
; 10(2)2022 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35214707
11.
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.
Sci Adv
; 8(51): eadd7197, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542720
12.
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
Viruses
; 13(10)2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696509
13.
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2.
Sci Rep
; 11(1): 14571, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272426
14.
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
Vaccines (Basel)
; 9(7)2021 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209694
15.
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.
Vaccines (Basel)
; 8(2)2020 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32532076
16.
Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine.
Sci Rep
; 10(1): 16261, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33004836
17.
High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals.
Sci Rep
; 8(1): 17505, 2018 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504788